Harikesh Pushpapathan

Partner at Stoic VC

📍 Australia🔄 Updated September 2026💼 2 investments📅 5 years investing🗓 Last invested Jan 2023
VC🌍 Australia
2
Total investments
0
Early stage
0
Mid stage
1
Late stage
5y
Years active

Portfolio

2 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Board Observer
Jan 2023
Lenexa Medical is an Australian-based MedTech company that has developed the LenexaCARE technology to empower clinicians to deliver targeted, long-term solutions for personalised pressure injury prevention and patient monitoring. Pressure injuries are mostly preventable, however affect millions of people globally each year whilst costing healthcare systems billions of dollars worldwide. In 2020, Australian public hospitals spent over $9 billion to address the issue. The LenexaCARE system consists of an ultra-thin fabric with in-built sensing capabilities and smart software for detecting and monitoring patient position, posture, and presence. By providing clinicians with non-subjective data to monitor positioning and presence of patients over time, LenexaCARE allows decisions to be made based on an individual’s unique profile and history on the mattress. The novel LenexaCARE technology will not only reduce the cost associated with pressure injury treatments and bed stays, but more importantly help to ease the pain and suffering for patients and their families.
Investor
Jan 2021
Various Companies
Experience · 10 entries
All (10)
Investments (2)
Founder (1)
Board (1)
2023
Investment Committee
Apr 2023
Antler is one of the most active early-stage investors globally. The firm leads in ‘Day Zero’ investing, an approach to venture capital focused on partnering with founders pre-launch. Antler systematically removes capital and network constraints for early-stage technology entrepreneurs by providing co-founder matching, deep business model validation, initial capital, expansion support, and follow-on funding. The firm is present in 27 cities across most leading technology ecosystems globally and has made over 1,300 investments into early-stage startups. Antler has been repeatedly recognized by Pitchbook as the world’s most active angel and seed-stage investor.
Board Observer
Jan 2023
Lenexa Medical is an Australian-based MedTech company that has developed the LenexaCARE technology to empower clinicians to deliver targeted, long-term solutions for personalised pressure injury prevention and patient monitoring. Pressure injuries are mostly preventable, however affect millions of people globally each year whilst costing healthcare systems billions of dollars worldwide. In 2020, Australian public hospitals spent over $9 billion to address the issue. The LenexaCARE system consists of an ultra-thin fabric with in-built sensing capabilities and smart software for detecting and monitoring patient position, posture, and presence. By providing clinicians with non-subjective data to monitor positioning and presence of patients over time, LenexaCARE allows decisions to be made based on an individual’s unique profile and history on the mattress. The novel LenexaCARE technology will not only reduce the cost associated with pressure injury treatments and bed stays, but more importantly help to ease the pain and suffering for patients and their families.
2022
Investment Committee
Feb 2022
Opus Venture Capital Funds specialise in backing leading early stage and seed stage AusIndustry ESVCLP managers with a specific focus on deep tech and core tech. With over $50m in committed capital we are one of the largest Australian VC fund of funds. Our core partners are Stoic Venture Capital ILP (www.stoicvc.com.au), Folklore Ventures ILP (www.folklore.vc) and Follow the Seed ILP (www.followtheseed.vc)
General Partner & Managing Partner
Jan 2022
At Stoic, were a big believer in life sciences but know that breakthrough innovation is found in all domains of research. We come in early, looking to partner with founders at the pre-seed and seed stage. Stoicism is what we believe equips founders with the right toolbox to navigate the uncertainties and challenges of building a generational company. Stoic VC is a venture capital fund investing in emerging science and frontier technologies at the seed and pre-seed stage.
2021
Associate
Aug 2021
Capital Capital is an independent advisory firm providing strategic, financial and transactional advice to our clients. We believe that our clients - founders & business leaders - deserve high-quality, honest, independent, and conflict-free advice from a team that shares their passion, vision & resilience. Our founding partners have deep expertise across all stages of a business’s life cycle with top-tier experience in advisory services across investment banking, mergers and acquisitions (M&A), corporate strategy, venture investments and more. One of our founding partners also has experience in founding and growing a business from two staff working out of a basement to over 100 people and a $100m valuation at exit. We have consulted on a broad range of assignments related to corporate development, capital raisings and M&A from pre-revenue start-up ventures to top 10 ASX-listed companies. And importantly, we have sat at all seats of the table - as a business seller, an acquirer, an investor, and as an advisor. So, when it comes to helping you and your business achieve your goals, we are uniquely placed. Get in touch with us today - we would love to learn more about you and your business, and how we can best partner with you.
Show all 10 entries ↓